Gwen Knight
Title
Cited by
Cited by
Year
The transmission of Mycobacterium tuberculosis in high burden settings
TA Yates, PY Khan, GM Knight, JG Taylor, TD McHugh, M Lipman, ...
The Lancet infectious diseases 16 (2), 227-238, 2016
1222016
Shift in dominant hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones over time
GM Knight, EL Budd, L Whitney, A Thornley, H Al-Ghusein, T Planche, ...
Journal of Antimicrobial Chemotherapy 67 (10), 2514-2522, 2012
1152012
Impact and cost-effectiveness of new tuberculosis vaccines in low-and middle-income countries
GM Knight, UK Griffiths, T Sumner, YV Laurence, A Gheorghe, A Vassall, ...
Proceedings of the National Academy of Sciences 111 (43), 15520-15525, 2014
1102014
Estimating the burden of antimicrobial resistance: a systematic literature review
NR Naylor, R Atun, N Zhu, K Kulasabanathan, S Silva, A Chatterjee, ...
Antimicrobial Resistance & Infection Control 7 (1), 58, 2018
1012018
The complex evolution of antibiotic resistance in Mycobacterium tuberculosis
JD Fonseca, GM Knight, TD McHugh
International journal of infectious diseases 32, 94-100, 2015
712015
Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose
JP Garnett, EH Baker, S Naik, JA Lindsay, GM Knight, S Gill, JS Tregoning, ...
Thorax 68 (9), 835-845, 2013
682013
Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines
RC Harris, T Sumner, GM Knight, RG White
Human vaccines & immunotherapeutics 12 (11), 2813-2832, 2016
432016
The distribution of fitness costs of resistance-conferring mutations is a key determinant for the future burden of drug-resistant tuberculosis: a model-based analysis
GM Knight, C Colijn, S Shrestha, M Fofana, F Cobelens, RG White, ...
Clinical Infectious Diseases 61 (suppl_3), S147-S154, 2015
382015
Within-host diversity of MRSA antimicrobial resistances
KI Stanczak-Mrozek, A Manne, GM Knight, K Gould, AA Witney, ...
Journal of Antimicrobial Chemotherapy 70 (8), 2191-2198, 2015
372015
Bridging the gap between evidence and policy for infectious diseases: How models can aid public health decision-making
GM Knight, NJ Dharan, GJ Fox, N Stennis, A Zwerling, R Khurana, ...
International journal of infectious diseases 42, 17-23, 2016
342016
Predicting the long-term impact of antiretroviral therapy scale-up on population incidence of tuberculosis
PJ Dodd, GM Knight, SD Lawn, EL Corbett, RG White
PloS one 8 (9), e75466, 2013
312013
Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling
GM Knight, CF McQuaid, PJ Dodd, RMGJ Houben
The Lancet Infectious Diseases 19 (8), 903-912, 2019
292019
Large mobile genetic elements carrying resistance genes that do not confer a fitness burden in healthcare-associated meticillin-resistant Staphylococcus aureus
GM Knight, EL Budd, JA Lindsay
Microbiology 159 (Pt_8), 1661-1672, 2013
242013
Ebola: the power of behaviour change
S Funk, GM Knight, VAA Jansen
Nature 515 (7528), 492-492, 2014
232014
Shuffling of mobile genetic elements (MGEs) in successful healthcare-associated MRSA (HA-MRSA)
JA Lindsay, GM Knight, EL Budd, AJ McCarthy
Mobile genetic elements 2 (5), 239-243, 2012
212012
Drivers and trajectories of resistance to new first-line drug regimens for tuberculosis
S Shrestha, GM Knight, M Fofana, T Cohen, RG White, F Cobelens, ...
Open forum infectious diseases 1 (2), 2014
192014
Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis
MO Fofana, GM Knight, GB Gomez, RG White, DW Dowdy
PloS one 9 (5), e96389, 2014
192014
A multistrain mathematical model to investigate the role of pyrazinamide in the emergence of extensively drug-resistant tuberculosis
MO Fofana, S Shrestha, GM Knight, T Cohen, RG White, F Cobelens, ...
Antimicrobial agents and chemotherapy 61 (3), 2017
172017
Tuberculosis prevention in South Africa
GM Knight, PJ Dodd, AD Grant, KL Fielding, GJ Churchyard, RG White
PLoS One 10 (4), e0122514, 2015
152015
What settings have been linked to SARS-CoV-2 transmission clusters?
QJ Leclerc, NM Fuller, LE Knight, S Funk, GM Knight, ...
Wellcome Open Research 5 (83), 83, 2020
112020
The system can't perform the operation now. Try again later.
Articles 1–20